PCN217 COST-EFFECTIVENESS OF LENVATINIB IN THE TREATMENT OF HEPATOCELLULAR CARCINOMA IN THE UK
Nov 1, 2019, 00:00 AM
10.1016/j.jval.2019.09.413
https://www.valueinhealthjournal.com/article/S1098-3015(19)32791-3/fulltext
Section Title :
Section Order :
10342
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32791-3&doi=10.1016/j.jval.2019.09.413